Cannabis

Cresco Labs reported its results for the first quarter of fiscal 2020 on May 28. The stock declined 4.2% and closed at $4.8 on the OTC markets yesterday.

Today, Canopy Growth reported its results for the fourth quarter of fiscal 2020. The company reported revenues of 107.9 million Canadian dollars.

OrganiGram (NASDAQ:OGI) had good news for patients who use cannabis for medical purposes. The company expanded its medical cannabis offerings.

So far in 2020, Green Thumb Industries has returned 6.0%—one of the few cannabis companies with positive returns this year.

MedMen released its results for the third quarter of fiscal 2020 on May 27. The stock declined 4.0% and closed at $0.35 on the OTC markets.

Despite the surge in May, Canopy Growth is still trading at a 54.3% discount from its 52-week high of $59.74. So, should you buy the stock?

Canopy Growth (NYSE:CGC)(TSE:WEED) will likely report its results for the fourth quarter of fiscal 2020 on May 29 before the market opens.

Cresco Labs (OTCMKTS:CRLBF) will likely report its financial results for the first quarter of fiscal 2020 on May 28 after the market closes.

MedMen Enterprises (OTCMKTS:MMNFF) is scheduled to report its financial results for the third quarter of fiscal 2020 on May 27 after the market closes.